AI, Attention and the Future of Healthcare | ...

In this episode, I sit down to discuss the biggest challenges and opportunities for the world's largest brands in 2026. We dive into why email is still a foundational and incredibly relevant channel, the biggest mistakes large companies make (from measuring reach to bad agency st ...  Show more

In this episode, I reveal why the greatest skill to have as a CEO is humility. I share my philosophy on authenticity, explaining that being your "full self" is the only path to true originality. I coach several successful entrepreneurs who are hitting scale, advising them on whet ...  Show more

What happens when people live decades longer than before—but not necessarily healthier? Iana Kouris, customer experience leader at BCG X, explores how companies can help people live longer healthier. Businesses can jumpstart the longevity economy by leveraging CX, behavioral desi ...  Show more

In this episode, Peter and Naveen discuss the future of healthcare, how AI will revolutionize our health, and how to raise Moonshot kids.    Recorded on July 22nd, 2024 Views are my own thoughts, not Financial, Medical, or Legal Advice. 05:04 | The Cost of Chronic Diseases 38 ...  Show more

Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI. At BIO-Europe, Norstella's subject matter experts explored key trends shaping the industry, from market access strategies to sustaining growth through partnerships. I ...  Show more

Artificial intelligence could help biopharmaceutical companies reduce costs as well as improve their chances of developing successful new drugs.

----- Transcript -----

Welcome to Thoughts on the Market. I'm Terence Flynn, Morgan Stanley's Head of U.S. Bi ...